Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3253 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Nuvelo terminates alfimeprase development

In the open-label, single-arm Phase II trial (Sonoma-3), alfimeprase restored catheter function in approximately 50% of patients at 15 minutes and approximately 60% of patients at one hour.